CoChat

Interaction of suppressor of cytokine signalling 3 with cavin-1 links SOCS3 function and cavin-1 stability

Open access

The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.

Abstract

Effective suppression of JAK–STAT signalling by the inducible inhibitor “suppressor of cytokine signalling 3” (SOCS3) is essential for limiting signalling from cytokine receptors. Here we show that cavin-1, a component of caveolae, is a functionally significant SOCS3-interacting protein. Biochemical and confocal imaging demonstrate that SOCS3 localisation to the plasma membrane requires cavin-1. SOCS3 is also critical for cavin-1 stabilisation, such that deletion of SOCS3 reduces the expression of cavin-1 and caveolin-1 proteins, thereby reducing caveola abundance in endothelial cells. Moreover, the interaction of cavin-1 and SOCS3 is essential for SOCS3 function, as loss of cavin-1 enhances cytokine-stimulated STAT3 phosphorylation and abolishes SOCS3-dependent inhibition of IL-6 signalling by cyclic AMP. Together, these findings reveal a new functionally important mechanism linking SOCS3-mediated inhibition of cytokine signalling to localisation at the plasma membrane via interaction with and stabilisation of cavin-1.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-017-02585-y

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Cavin-1 stability is enhanced in the presence of SOCS3. a HEK293 cells co-transfected with fixed amounts of either myc-tagged FAK1 or GFP-cavin-1 expression constructs and increasing levels of Flag-SOCS3 were treated with or without proteasome inhibitor MG132 (6 μM) as indicated. Detergent-soluble whole-cell lysates were analysed by SDS-PAGE and immunoblotting. b Detergent-soluble whole-cell lysates prepared from SOCS3+/+ (+/+) and SOCS3−/− (−/−) MEFs equalised for protein content were analysed by SDS-PAGE and immunoblotting. c Quantitative real-time PCR of cavin-1 mRNA levels in WT (SOCS3+/+) and SOCS3−/− MEFs. Data are presented as mean ± standard error for N = 3 experiments. d Upper: Protein-equalised soluble cell extracts from SOCS3+/+ and SOCS3−/− MEFs chased for the indicated times in serum-free medium with protein synthesis inhibitor emetine (100 μM) were analysed by SDS-PAGE and immunoblotting with the indicated antibodies. Lower: Quantitation of cavin-1 levels in SOCS3+/+ and SOCS3−/− MEFs is also shown. Results are presented as mean values ± standard error for N = 3 experiments. *P < 0.05 vs. corresponding treatment in SOCS3+/+ MEFs, ψP < 0.05 vs. t = 0
Fig. 1 Cavin-1 stability is enhanced in the presence of SOCS3. a HEK293 cells co-transfected with fixed amounts of either myc-tagged FAK1 or GFP-cavin-1 expression constructs and increasing levels of Flag-SOCS3 were treated with or without proteasome inhibitor MG132 (6 μM) as indicated. Detergent-soluble whole-cell lysates were analysed by SDS-PAGE and immunoblotting. b Detergent-soluble whole-cell lysates prepared from SOCS3+/+ (+/+) and SOCS3−/− (−/−) MEFs equalised for protein content were analysed by SDS-PAGE and immunoblotting. c Quantitative real-time PCR of cavin-1 mRNA levels in WT (SOCS3+/+) and SOCS3−/− MEFs. Data are presented as mean ± standard error for N = 3 experiments. d Upper: Protein-equalised soluble cell extracts from SOCS3+/+ and SOCS3−/− MEFs chased for the indicated times in serum-free medium with protein synthesis inhibitor emetine (100 μM) were analysed by SDS-PAGE and immunoblotting with the indicated antibodies. Lower: Quantitation of cavin-1 levels in SOCS3+/+ and SOCS3−/− MEFs is also shown. Results are presented as mean values ± standard error for N = 3 experiments. *P < 0.05 vs. corresponding treatment in SOCS3+/+ MEFs, ψP < 0.05 vs. t = 0CC BY · PubMed Central
Fig. 2 Effect of SOCS3 deletion on caveola abundance in endothelial cells. a Upper: Detergent-soluble whole-cell lysates from WT and SOCS3-null AS-M.5 human angiosarcoma-derived ECs treated with either vehicle or 50 μM Fsk for 5 h were equalised for protein content for SDS-PAGE for immunoblotting with the indicated antibodies. Lower: Quantitation of cavin-1 and caveolin-1 protein levels in unstimulated AS-M.5 cells is presented as mean ± standard error for N = 3 experiments. *P < 0.05, **P < 0.01 vs. WT cells. b Transmitting electron microscopy (TEM) was performed on WT and SOCS3-null AS-M.5 cells as indicated. Cell surface caveolae (indicated by the arrows) were readily detectable in WT cells (left panel). In contrast, plasma membranes from SOCS3-null cells were flat and caveolae density was significantly reduced compared to WT cells (right panel). Scale bar = 0.5 μm. c Quantitation of caveola density (number of caveolae per μm of plasma membrane) in WT and SOCS3-null AS-M.5 cells. ***P < 0.0001 vs. WT cells
Fig. 2 Effect of SOCS3 deletion on caveola abundance in endothelial cells. a Upper: Detergent-soluble whole-cell lysates from WT and SOCS3-null AS-M.5 human angiosarcoma-derived ECs treated with either vehicle or 50 μM Fsk for 5 h were equalised for protein content for SDS-PAGE for immunoblotting with the indicated antibodies. Lower: Quantitation of cavin-1 and caveolin-1 protein levels in unstimulated AS-M.5 cells is presented as mean ± standard error for N = 3 experiments. *P < 0.05, **P < 0.01 vs. WT cells. b Transmitting electron microscopy (TEM) was performed on WT and SOCS3-null AS-M.5 cells as indicated. Cell surface caveolae (indicated by the arrows) were readily detectable in WT cells (left panel). In contrast, plasma membranes from SOCS3-null cells were flat and caveolae density was significantly reduced compared to WT cells (right panel). Scale bar = 0.5 μm. c Quantitation of caveola density (number of caveolae per μm of plasma membrane) in WT and SOCS3-null AS-M.5 cells. ***P < 0.0001 vs. WT cellsCC BY · PubMed Central
Fig. 3 A region within the SOCS3 SH2 domain is necessary and sufficient for cavin-1 interaction. a Protein-equalised soluble cell extracts from HEK293 cells transfected with expression constructs encoding Flag-SOCS3 and myc-tagged cavin-1 as indicated were processed by immunoprecipitation (IP) with anti-Flag M2-agarose beads prior to SDS-PAGE and immunoblotting with the indicated antibodies. Whole-cell lysates from the samples used in the IP were also fractionated by SDS-PAGE for immunoblotting in parallel. b Protein-equalised soluble cell extracts from WT and SOCS3-null AS-M.5 cells treated with 50 μM Fsk and 6 μM MG132 for 4 h were processed by IP with anti-cavin-1 antibody prior to SDS-PAGE and immunoblotting with the indicated antibodies. As loss of SOCS3 in AS-M.5 cells reduces cavin-1 protein levels (a), twice the amount of protein was used as input for SOCS3-null cells to compensate. NS = non-specific band. c Upper: Protein-equalised soluble cell extracts from HEK293 cells transfected with expression constructs encoding either Flag-tagged WT SOCS3 or the indicated truncation mutants and GFP-tagged cavin-1 as indicated were processed by IP with anti-Flag M2-agarose beads prior to SDS-PAGE and immunoblotting with the indicated antibodies. Whole-cell lysates from the same samples used in the IP were also fractionated by SDS-PAGE for immunoblotting in parallel. Lower: Schematic of the SOCS3 truncation constructs used, KIR = kinase inhibitory region, ESS = extended SH2 subdomain, PEST = PEST (ProGluSerThr) motif. d Upper: Protein-equalised soluble cell extracts from HEK293 cells co-transfected with expression constructs encoding either full-length SOCS3 (WT), a truncated ΔSH2 SOCS3domain (ΔSH2), or SOCS box domain (SB) fused to GFP and myc-tagged cavin-1 as indicated were processed by IP with anti-GFP antibody and protein G-Sepharose beads prior to SDS-PAGE and immunoblotting with the indicated antibodies. Whole-cell lysates from the same samples used in the IP were also fractionated by SDS-PAGE and for immunoblotting in parallel. Lower: Schematic of the SOCS3-GFP fusions used
Fig. 3 A region within the SOCS3 SH2 domain is necessary and sufficient for cavin-1 interaction. a Protein-equalised soluble cell extracts from HEK293 cells transfected with expression constructs encoding Flag-SOCS3 and myc-tagged cavin-1 as indicated were processed by immunoprecipitation (IP) with anti-Flag M2-agarose beads prior to SDS-PAGE and immunoblotting with the indicated antibodies. Whole-cell lysates from the samples used in the IP were also fractionated by SDS-PAGE for immunoblotting in parallel. b Protein-equalised soluble cell extracts from WT and SOCS3-null AS-M.5 cells treated with 50 μM Fsk and 6 μM MG132 for 4 h were processed by IP with anti-cavin-1 antibody prior to SDS-PAGE and immunoblotting with the indicated antibodies. As loss of SOCS3 in AS-M.5 cells reduces cavin-1 protein levels (a), twice the amount of protein was used as input for SOCS3-null cells to compensate. NS = non-specific band. c Upper: Protein-equalised soluble cell extracts from HEK293 cells transfected with expression constructs encoding either Flag-tagged WT SOCS3 or the indicated truncation mutants and GFP-tagged cavin-1 as indicated were processed by IP with anti-Flag M2-agarose beads prior to SDS-PAGE and immunoblotting with the indicated antibodies. Whole-cell lysates from the same samples used in the IP were also fractionated by SDS-PAGE for immunoblotting in parallel. Lower: Schematic of the SOCS3 truncation constructs used, KIR = kinase inhibitory region, ESS = extended SH2 subdomain, PEST = PEST (ProGluSerThr) motif. d Upper: Protein-equalised soluble cell extracts from HEK293 cells co-transfected with expression constructs encoding either full-length SOCS3 (WT), a truncated ΔSH2 SOCS3domain (ΔSH2), or SOCS box domain (SB) fused to GFP and myc-tagged cavin-1 as indicated were processed by IP with anti-GFP antibody and protein G-Sepharose beads prior to SDS-PAGE and immunoblotting with the indicated antibodies. Whole-cell lysates from the same samples used in the IP were also fractionated by SDS-PAGE and for immunoblotting in parallel. Lower: Schematic of the SOCS3-GFP fusions usedCC BY · PubMed Central
Fig. 4 Cavin-1–SOCS3 interaction occurs independently of the PTyr binding capacity of the SH2 domain. a HEK293 cells transfected with expression constructs encoding Flag-SOCS3 and GFP-tagged cavin-1 as indicated were treated with or without Tyr phosphatase inhibitors sodium orthovanadate (Van: 1 mM) for 1.5 h and then hydrogen peroxide (H2O2: 0.2 mM) for an additional 30 min prior to harvesting. Protein-equalised soluble cell extracts were then processed by IP with anti-Flag M2-agarose beads prior to SDS-PAGE and immunoblotting with the indicated antibodies. Whole-cell lysates from the samples used in the IP were also fractionated by SDS-PAGE for immunoblotting in parallel. b Protein-equalised soluble cell extracts from HEK293 cells transfected with expression constructs encoding either WT or R71K-mutated Flag-SOCS3 and GFP-tagged-cavin-1 as indicated were processed by IP with anti-Flag M2-agarose beads prior to SDS-PAGE and immunoblotting with the indicated antibodies. Whole-cell lysates from the samples used in the IP were also fractionated by SDS-PAGE for immunoblotting in parallel. c Protein-equalised soluble cell extracts from HEK293 cells transfected with expression constructs encoding WT Flag-SOCS3 and GFP-tagged cavin-1 as indicated were incubated with 100 nM N-terminally biotinylated peptides corresponding to the Tyr759 motif of gp130 in its phosphorylated (pY) or non-phosphorylated (Y) forms or a scrambled control (Scr) and streptavidin–agarose beads prior to SDS-PAGE and immunoblotting with the indicated antibodies. Whole-cell lysates from the samples used in the pull-down were also fractionated by SDS-PAGE for immunoblotting in parallel
Fig. 4 Cavin-1–SOCS3 interaction occurs independently of the PTyr binding capacity of the SH2 domain. a HEK293 cells transfected with expression constructs encoding Flag-SOCS3 and GFP-tagged cavin-1 as indicated were treated with or without Tyr phosphatase inhibitors sodium orthovanadate (Van: 1 mM) for 1.5 h and then hydrogen peroxide (H2O2: 0.2 mM) for an additional 30 min prior to harvesting. Protein-equalised soluble cell extracts were then processed by IP with anti-Flag M2-agarose beads prior to SDS-PAGE and immunoblotting with the indicated antibodies. Whole-cell lysates from the samples used in the IP were also fractionated by SDS-PAGE for immunoblotting in parallel. b Protein-equalised soluble cell extracts from HEK293 cells transfected with expression constructs encoding either WT or R71K-mutated Flag-SOCS3 and GFP-tagged-cavin-1 as indicated were processed by IP with anti-Flag M2-agarose beads prior to SDS-PAGE and immunoblotting with the indicated antibodies. Whole-cell lysates from the samples used in the IP were also fractionated by SDS-PAGE for immunoblotting in parallel. c Protein-equalised soluble cell extracts from HEK293 cells transfected with expression constructs encoding WT Flag-SOCS3 and GFP-tagged cavin-1 as indicated were incubated with 100 nM N-terminally biotinylated peptides corresponding to the Tyr759 motif of gp130 in its phosphorylated (pY) or non-phosphorylated (Y) forms or a scrambled control (Scr) and streptavidin–agarose beads prior to SDS-PAGE and immunoblotting with the indicated antibodies. Whole-cell lysates from the samples used in the pull-down were also fractionated by SDS-PAGE for immunoblotting in parallelCC BY · PubMed Central
Fig. 5 Cavin-1–SOCS3 interaction requires the SOCS3 SH2 PEST motif. a Protein-equalised soluble cell extracts from HEK293 cells transfected with expression constructs encoding either WT or ΔPEST Flag-SOCS3 were incubated with 100 nM N-terminally biotinylated peptides corresponding to the Tyr759 motif of gp130 in its phosphorylated (pY) or non-phosphorylated (Y) forms and streptavidin–agarose beads prior to loading with whole-cell lysate samples for SDS-PAGE and immunoblotting with the indicated antibodies. b Protein-equalised soluble cell extracts from HEK293 cells transfected with expression constructs encoding either WT or ΔPEST Flag-SOCS3 and GFP-tagged cavin-1 as indicated were processed by IP with anti-Flag M2-agarose beads prior to SDS-PAGE and immunoblotting with the indicated antibodies. Whole-cell lysates from the samples used in the IP were also fractionated by SDS-PAGE for immunoblotting in parallel. c Upper, Protein-equalised soluble cell extracts from HEK293 cells transfected with or without the indicated CIS and SOCS3 expression constructs and GFP-tagged cavin-1 as indicated were processed by IP with anti-Flag M2-agarose beads prior to SDS-PAGE and immunoblotting with the indicated antibodies. Whole-cell lysates from the samples used in the IP were also fractionated by SDS-PAGE for immunoblotting in parallel. Lower, Schematic of CIS and SOCS3. d Protein-equalised soluble cell extracts from HEK293 cells transfected with or without the indicated SOCS3 and Grap2 expression constructs and GFP-tagged cavin-1 as indicated were processed by IP with anti-Flag M2-agarose beads prior to SDS-PAGE and immunoblotting with the indicated antibodies. Whole-cell lysates from the samples used in the IP were also fractionated by SDS-PAGE for immunoblotting in parallel
Fig. 5 Cavin-1–SOCS3 interaction requires the SOCS3 SH2 PEST motif. a Protein-equalised soluble cell extracts from HEK293 cells transfected with expression constructs encoding either WT or ΔPEST Flag-SOCS3 were incubated with 100 nM N-terminally biotinylated peptides corresponding to the Tyr759 motif of gp130 in its phosphorylated (pY) or non-phosphorylated (Y) forms and streptavidin–agarose beads prior to loading with whole-cell lysate samples for SDS-PAGE and immunoblotting with the indicated antibodies. b Protein-equalised soluble cell extracts from HEK293 cells transfected with expression constructs encoding either WT or ΔPEST Flag-SOCS3 and GFP-tagged cavin-1 as indicated were processed by IP with anti-Flag M2-agarose beads prior to SDS-PAGE and immunoblotting with the indicated antibodies. Whole-cell lysates from the samples used in the IP were also fractionated by SDS-PAGE for immunoblotting in parallel. c Upper, Protein-equalised soluble cell extracts from HEK293 cells transfected with or without the indicated CIS and SOCS3 expression constructs and GFP-tagged cavin-1 as indicated were processed by IP with anti-Flag M2-agarose beads prior to SDS-PAGE and immunoblotting with the indicated antibodies. Whole-cell lysates from the samples used in the IP were also fractionated by SDS-PAGE for immunoblotting in parallel. Lower, Schematic of CIS and SOCS3. d Protein-equalised soluble cell extracts from HEK293 cells transfected with or without the indicated SOCS3 and Grap2 expression constructs and GFP-tagged cavin-1 as indicated were processed by IP with anti-Flag M2-agarose beads prior to SDS-PAGE and immunoblotting with the indicated antibodies. Whole-cell lysates from the samples used in the IP were also fractionated by SDS-PAGE for immunoblotting in parallelCC BY · PubMed Central
Fig. 6 SOCS3 interacts with multiple regions within cavin-1. a An immobilised library of 25-mer peptides sequentially shifted by 5 amino acids along the entire cavin-1 open reading frame was overlaid with either purified SOCS3 or a negative control (Cntrl). Dark spots represent areas of interaction between SOCS3 and peptides within the cavin-1 peptide array. The domain structure of murine cavin-1 is indicated below the overlay. b Schematic representation of the N- and C-terminally truncated myc-tagged cavin-1 mutants used for co-IP experiments. c Protein-equalised soluble cell extracts from HEK293 cells transfected with expression constructs encoding either myc-tagged WT cavin-1 or the indicated truncation mutants and Flag-tagged SOCS3 as indicated were processed by IP with anti-Flag M2-agarose beads prior to SDS-PAGE and immunoblotting with the indicated antibodies. Whole-cell lysates from the same samples used in the IP were also fractionated by SDS-PAGE for immunoblotting in parallel. *Indicates that expression of the C1 cavin-1 mutant was not detectable; Non Spec refers to immunoglobulin-derived non-specific staining
Fig. 6 SOCS3 interacts with multiple regions within cavin-1. a An immobilised library of 25-mer peptides sequentially shifted by 5 amino acids along the entire cavin-1 open reading frame was overlaid with either purified SOCS3 or a negative control (Cntrl). Dark spots represent areas of interaction between SOCS3 and peptides within the cavin-1 peptide array. The domain structure of murine cavin-1 is indicated below the overlay. b Schematic representation of the N- and C-terminally truncated myc-tagged cavin-1 mutants used for co-IP experiments. c Protein-equalised soluble cell extracts from HEK293 cells transfected with expression constructs encoding either myc-tagged WT cavin-1 or the indicated truncation mutants and Flag-tagged SOCS3 as indicated were processed by IP with anti-Flag M2-agarose beads prior to SDS-PAGE and immunoblotting with the indicated antibodies. Whole-cell lysates from the same samples used in the IP were also fractionated by SDS-PAGE for immunoblotting in parallel. *Indicates that expression of the C1 cavin-1 mutant was not detectable; Non Spec refers to immunoglobulin-derived non-specific stainingCC BY · PubMed Central
Fig. 7 Cavin-1 drives SOCS3 localisation to the plasma membrane. a WT (cavin-1+/+) and cavin-1−/− MEFs transiently expressing SOCS3-GFP (green) were stained with DAPI prior to being fixed, solubilised, and stained with anti-cavin-1 antibody (red) before mounting for imaging by confocal microscopy. Areas of red and green overlap are yellow. Scale bar = 10 μm. b Pearson's correlation coefficient value (r2) measured from the intensity values located within the rectangular region on the plasma membrane superimposed on the merged cavin-1/SOCS3-GFP image from WT MEFs. c Cavin-1−/− MEFs transiently co-expressing SOCS3-GFP (green) and cavin-1-mCh (red) were stained with Hoechst 33342 prior to being fixed for imaging by confocal microscopy. Areas of red and green overlap are yellow. Scale bar = 10 μm. d WT, SOCS3−/−, and cavin-1−/− MEFs were pre-incubated with Fsk (50 μM) for 5 h to induce SOCS3 prior to subcellular fractionation and analysis by SDS-PAGE and immunoblotting with the indicated antibodies
Fig. 7 Cavin-1 drives SOCS3 localisation to the plasma membrane. a WT (cavin-1+/+) and cavin-1−/− MEFs transiently expressing SOCS3-GFP (green) were stained with DAPI prior to being fixed, solubilised, and stained with anti-cavin-1 antibody (red) before mounting for imaging by confocal microscopy. Areas of red and green overlap are yellow. Scale bar = 10 μm. b Pearson's correlation coefficient value (r2) measured from the intensity values located within the rectangular region on the plasma membrane superimposed on the merged cavin-1/SOCS3-GFP image from WT MEFs. c Cavin-1−/− MEFs transiently co-expressing SOCS3-GFP (green) and cavin-1-mCh (red) were stained with Hoechst 33342 prior to being fixed for imaging by confocal microscopy. Areas of red and green overlap are yellow. Scale bar = 10 μm. d WT, SOCS3−/−, and cavin-1−/− MEFs were pre-incubated with Fsk (50 μM) for 5 h to induce SOCS3 prior to subcellular fractionation and analysis by SDS-PAGE and immunoblotting with the indicated antibodiesCC BY · PubMed Central
Fig. 8 Cavin-1 limits Tyr705 phosphorylation of STAT3 via SOCS3. a Upper: Protein-equalised soluble cell extracts from cavin-1+/+ and cavin-1−/− MEFs treated for the indicated times with sIL-6Rα/IL-6 (25 and 5 ng ml−1) were fractionated by SDS-PAGE prior to immunoblotting with the indicated antibodies. Quantitation of normalised Tyr705 phospho-STAT3 in cavin-1+/+ and cavin-1−/− MEFs are presented as mean values ± standard error for N = 3 experiments. *P < 0.05, **P < 0.01, ***P < 0.001 vs. corresponding treatment in cavin-1+/+ MEFs. b Protein-equalised soluble cell extracts from cavin-1+/+ and cavin-1−/− MEFs treated for 30 and 60 min with leukaemia inhibitory factor (LIF; 0.5 nM), oncostatin M (OSM; 10 ng ml−1) or vehicle (V) were fractionated by SDS-PAGE prior to immunoblotting with the indicated antibodies. c Upper: WT (cavin-1+/+) and cavin-1−/− MEFs were pre-incubated with or without Fsk (50 μM) for 5 h prior to treatment with or without sIL-Rα/IL-6 (25 and 5 ng ml−1) for 30 min. Cell extracts were analysed by SDS-PAGE and immunoblotting with the indicated antibodies. Lower: Quantitation of normalised Tyr705 phospho-STAT3 and SOCS3 in cavin-1+/+ and cavin-1−/− MEFs is presented as mean ± standard error for N = 3 experiments, *P < 0.05 vs. sIL-6Rα/IL-6 treatment in cavin-1+/+ MEFs, #P < 0.05 vs. vehicle treatment in cavin-1−/− MEFs.
Fig. 8 Cavin-1 limits Tyr705 phosphorylation of STAT3 via SOCS3. a Upper: Protein-equalised soluble cell extracts from cavin-1+/+ and cavin-1−/− MEFs treated for the indicated times with sIL-6Rα/IL-6 (25 and 5 ng ml−1) were fractionated by SDS-PAGE prior to immunoblotting with the indicated antibodies. Quantitation of normalised Tyr705 phospho-STAT3 in cavin-1+/+ and cavin-1−/− MEFs are presented as mean values ± standard error for N = 3 experiments. *P < 0.05, **P < 0.01, ***P < 0.001 vs. corresponding treatment in cavin-1+/+ MEFs. b Protein-equalised soluble cell extracts from cavin-1+/+ and cavin-1−/− MEFs treated for 30 and 60 min with leukaemia inhibitory factor (LIF; 0.5 nM), oncostatin M (OSM; 10 ng ml−1) or vehicle (V) were fractionated by SDS-PAGE prior to immunoblotting with the indicated antibodies. c Upper: WT (cavin-1+/+) and cavin-1−/− MEFs were pre-incubated with or without Fsk (50 μM) for 5 h prior to treatment with or without sIL-Rα/IL-6 (25 and 5 ng ml−1) for 30 min. Cell extracts were analysed by SDS-PAGE and immunoblotting with the indicated antibodies. Lower: Quantitation of normalised Tyr705 phospho-STAT3 and SOCS3 in cavin-1+/+ and cavin-1−/− MEFs is presented as mean ± standard error for N = 3 experiments, *P < 0.05 vs. sIL-6Rα/IL-6 treatment in cavin-1+/+ MEFs, #P < 0.05 vs. vehicle treatment in cavin-1−/− MEFs.CC BY · PubMed Central
Fig. 9 Model of novel functional interactions between SOCS3 and cavin-1
Fig. 9 Model of novel functional interactions between SOCS3 and cavin-1CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 73 references

Research works printed but not linked: 3

  1. Palade, G. Fine structure of blood capillaries. J. Appl. Phys. 24, 1424 (1953).
  2. Tagwerker, C. et al. A tandem affinity tag for two-step purification under fully denaturing conditions: application in ubiquitin profiling and protein complex identification combined with in vivo cross-linking. Mol. Cell. Proteom. 5, 737–748 (2006). · DOI · Paper page
  3. Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367–1372 (2008). · DOI · Paper page

Cited by

See all 36

Metadata

Authors
Williams, J. J. L., Alotaiq, N., Mullen, W., Burchmore, R., Liu, L., Baillie, G. S., Schaper, F., Pilch, P. F., & Palmer, T. M.
Affiliations
  • University of Bradford (GB)
  • University of Glasgow (GB)
  • Boston University (US)
  • Otto-von-Guericke-Universität Magdeburg (DE)
Corresponding author
  • Williams, Jamie J. L.
  • Palmer, Timothy M.
Venue
Nature Communications
Published
2018-01-12
Volume
9
Issue
1
Pages
168-168
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2782917952
Cited by
35
References
73
Citations by year
2026: 2 · 2025: 5 · 2022: 7 · 2021: 2 · 2020: 9 · 2019: 9 · 2018: 1
FWCI
1.97
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Bradford Scholars (University of Bradford) (publishedVersion, other-oa)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, cc-by-sa)
  • Repository@Hull (Worktribe) (University of Hull) (submittedVersion, cc-by)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • British Heart Foundation (PG/12/1/29276, PG/14/32/30812)
  • Diabetes UK (11/0004309)
  • University of Glasgow
  • National Institutes of Health
  • Directorate for Biological Sciences
  • Biotechnology and Biological Sciences Research Council (BB/F016735, BB/F016735/1)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK112945, R01DK097708)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Caveolin-1 and cellular processes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
Keywords
SOCS3, cavin-1, caveolae, caveolin-1, JAK/STAT signaling, STAT3 phosphorylation, IL-6 signaling, protein stability, protein-protein interaction, plasma membrane localization, endothelial cells, cyclic AMP
MeSH terms
Suppressor of Cytokine Signaling 3 Protein, Animals, Gene Expression Regulation, Humans, Membrane Proteins, Protein Binding, RNA-Binding Proteins, Gene Deletion, Caveolae, STAT Transcription Factors, Mice, Janus Kinases, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Interaction of suppressor of cytokine signalling 3 with cavin-1 links SOCS3 function and cavin-1 stability. https://app.cochat.ai/papers/10.1038/s41467-017-02585-y
The paper
Williams, J. J. L., Alotaiq, N., Mullen, W., Burchmore, R., Liu, L., Baillie, G. S., Schaper, F., Pilch, P. F., & Palmer, T. M. (2018). Interaction of suppressor of cytokine signalling 3 with cavin-1 links SOCS3 function and cavin-1 stability. Nature Communications. https://doi.org/10.1038/s41467-017-02585-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.